| Breakdown | TTM | Jan 2025 | Jan 2024 | Jan 2023 | Jan 2022 | Jan 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 187.14B | 130.50B | 60.92B | 26.97B | 26.91B | 16.68B |
| Gross Profit | 131.09B | 97.86B | 44.30B | 15.36B | 17.48B | 10.40B |
| EBITDA | 119.09B | 86.14B | 35.58B | 5.99B | 11.35B | 5.69B |
| Net Income | 99.20B | 72.88B | 29.76B | 4.37B | 9.75B | 4.33B |
Balance Sheet | ||||||
| Total Assets | 161.15B | 111.60B | 65.73B | 41.18B | 44.19B | 28.79B |
| Cash, Cash Equivalents and Short-Term Investments | 60.61B | 43.21B | 25.98B | 13.30B | 21.21B | 11.56B |
| Total Debt | 10.82B | 10.27B | 11.06B | 12.03B | 11.83B | 7.72B |
| Total Liabilities | 42.25B | 32.27B | 22.75B | 19.08B | 17.57B | 11.90B |
| Stockholders Equity | 118.90B | 79.33B | 42.98B | 22.10B | 26.61B | 16.89B |
Cash Flow | ||||||
| Free Cash Flow | 77.32B | 60.85B | 27.02B | 3.81B | 8.13B | 4.69B |
| Operating Cash Flow | 83.16B | 64.09B | 28.09B | 5.64B | 9.11B | 5.82B |
| Investing Cash Flow | -28.57B | -20.42B | -10.57B | 7.38B | -9.83B | -19.68B |
| Financing Cash Flow | -52.22B | -42.36B | -13.63B | -11.62B | 1.86B | 3.80B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | $1.57T | 34.08 | 36.46% | 0.82% | 39.73% | 56.22% | |
76 Outperform | $4.57T | 46.56 | 107.36% | 0.02% | 65.22% | 58.53% | |
73 Outperform | $1.58T | 69.99 | 31.05% | 0.69% | 23.87% | 285.84% | |
71 Outperform | $326.28B | 76.89 | 7.08% | ― | 31.83% | 80.45% | |
64 Neutral | $152.84B | 29.59 | 21.48% | 2.01% | 13.66% | -45.40% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
57 Neutral | $227.07B | -544.81 | -0.25% | ― | -1.49% | ― |